Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Change in Inventory of -$5000.0 for Q1 2026, up 83.33% year-over-year from -$2727.3 in Q1 2025, and down 104.07% quarter-over-quarter from $123000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 8 years of Change in Inventory data on file, last reported at -$5000.0 in Q1 2026.
- Change in Inventory for Q1 2026 came in at -$5000.0, up 83.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $75000.0 (up 123.96% YoY), and the FY2025 annual result was $50000.0, up 133.33% from the prior year.
- Change in Inventory declined to -$5000.0 in Q1 2026 per LXRX's latest filing, from $123000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $172000.0 in Q2 2023 and troughed at -$405000.0 in Q4 2024.
- A 4-year average of $23000.0 and a median of $48000.0 in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory slumped 1000.0% in 2024, then jumped 130.37% in 2025.
- A 4-year view of Change in Inventory shows it stood at $45000.0 in 2023, then tumbled by 1000.0% to -$405000.0 in 2024, then jumped by 130.37% to $123000.0 in 2025, then plunged by 104.07% to -$5000.0 in 2026.
- Business Quant data shows LXRX's Change in Inventory at -$5000.0 in Q1 2026, $123000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -405,000.00 |
| Dec 31, 2024 | -405,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 71,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Dec 31, 2023 | 45,000.00 |